Celltrion stands as a prominent player in the Korean pharmaceutical landscape, accomplishing a feat once deemed improbable introducing the world's first "antibody biosimilar" from a nation with a comparatively less developed pharmaceutical sector. The company has boldly ventured into unexplored territories, achieving remarkable success. Building on this momentum, Celltrion is poised to further expand its footprint as a global ...
Celltrion stands as a prominent player in the Korean pharmaceutical landscape, accomplishing a feat once deemed improbable introducing the world's first "antibody biosimilar" from a nation with a comparatively less developed pharmaceutical sector. The company has boldly ventured into unexplored territories, achieving remarkable success. Building on this momentum, Celltrion is poised to further expand its footprint as a global biopharmaceutical entity, showcasing distinctive strategies in areas like small molecule pharmaceuticals and pioneering ventures such as the Ubiquitous healthcare platform business.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.